Wall Street is positive on Mersana Therapeutics Inc (MRSN). On average, analysts give MRSN a Buy rating. The average price target is $5.285, which means analysts expect the stock to increase by 277.50% over the next twelve months.
That average ranking earns MRSN an Analyst Rating of 15, which is better than 15% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating MRSN a Buy today. Find out what this means to you and get the rest of the rankings on MRSN!
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Mersana Therapeutics Inc Stock Today?
Mersana Therapeutics Inc (MRSN) stock is trading at $1.40 as of 12:44 PM on Friday, Nov 3, a gain of $0.12, or 9.38% from the previous closing price of $1.28. The stock has traded between $1.25 and $1.47 so far today. Volume today is less active than usual. So far 770,676 shares have traded compared to average volume of 2,067,938 shares.
Click Here to get the full Stock Report for Mersana Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
